Loading…
Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae
Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium (VcCA) presents an alternative therapeutic target. In this s...
Saved in:
Published in: | International journal of molecular sciences 2020-04, Vol.21 (9), p.3131 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443 |
---|---|
cites | cdi_FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443 |
container_end_page | |
container_issue | 9 |
container_start_page | 3131 |
container_title | International journal of molecular sciences |
container_volume | 21 |
creator | Demir-Yazıcı, Kübra Güzel-Akdemir, Özlen Angeli, Andrea Supuran, Claudiu T Akdemir, Atilla |
description | Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium
(VcCA) presents an alternative therapeutic target. In this study, a series of hydrazone derivatives, carrying the 2-(hydrazinocarbonyl)-3-phenyl-1
-indole-5-sulfonamide scaffold, have been evaluated as inhibitors of the VcCA with molecular modeling studies. The results suggest that these compounds may bind to the active site of VcCA. To verify this, VcCA enzyme inhibition studies were performed and as predicted most of the tested compounds displayed potent inhibitory activities against VcCA with three compounds showing
values lower than 30 nM. In addition, all these compounds showed selectivity for VcCA and the off-targets hCA I and II. |
doi_str_mv | 10.3390/ijms21093131 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7247680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2398642396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443</originalsourceid><addsrcrecordid>eNpdkctu1TAURS1ERUthxhhZYtJBA34kTjxBaq9KW6mCDoCp5cdx46skLnZSqUz4Jn6Eb6ovfejC5PhIe3nbWxuhN5S851ySD2E9ZkaJ5JTTZ2iP1oxVhIj2-da-i17mvCaEcdbIF2iXMy6aumN76NfneAMDPp9cHKA61hkcPrt1Sf-ME2SsM76MM0xzIfpgwhxTxtHjuQf853dlB50zXulk4hQsPpr6zdUM2Kc44ks99_EKNsqxtjOksIz4ezApRGz78l7S8ArteD1keP1w7qNvn06-rs6qiy-n56uji8rWlM2V7ljrCWPeNrRlsnFONrqTDqiXvvWcA9GMCiI7YIQZQ5wR3nRGdrUUrq75Pvp473u9mBGcLZGSHtR1CqNOtyrqoP5VptCrq3ijWla3oiPF4ODBIMUfC-RZjSFbGAY9QVyyYlx2oi5TFPTdf-g6Lmkq8f5SRDAp20Id3lM2xZwT-KfPUKI2zartZgv-djvAE_xYJb8Dopmhjw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2398062997</pqid></control><display><type>article</type><title>Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Demir-Yazıcı, Kübra ; Güzel-Akdemir, Özlen ; Angeli, Andrea ; Supuran, Claudiu T ; Akdemir, Atilla</creator><creatorcontrib>Demir-Yazıcı, Kübra ; Güzel-Akdemir, Özlen ; Angeli, Andrea ; Supuran, Claudiu T ; Akdemir, Atilla</creatorcontrib><description>Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium
(VcCA) presents an alternative therapeutic target. In this study, a series of hydrazone derivatives, carrying the 2-(hydrazinocarbonyl)-3-phenyl-1
-indole-5-sulfonamide scaffold, have been evaluated as inhibitors of the VcCA with molecular modeling studies. The results suggest that these compounds may bind to the active site of VcCA. To verify this, VcCA enzyme inhibition studies were performed and as predicted most of the tested compounds displayed potent inhibitory activities against VcCA with three compounds showing
values lower than 30 nM. In addition, all these compounds showed selectivity for VcCA and the off-targets hCA I and II.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21093131</identifier><identifier>PMID: 32365482</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Amino Acid Sequence ; Amino acids ; Antibiotics ; Antimicrobial agents ; Bacteria ; Binding Sites ; Carbonic anhydrase ; Carbonic Anhydrase Inhibitors - chemistry ; Carbonic Anhydrase Inhibitors - pharmacology ; Cholera ; Crystal structure ; Drug development ; Enzyme Activation ; Enzymes ; Epidemics ; Gene expression ; Hydrazones ; Hydrazones - chemistry ; Hydrogen bonds ; Indoles ; Indoles - chemistry ; Inhibitors ; Ligands ; Molecular Conformation ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Molecular modelling ; Molecular Structure ; Protein Binding ; Selectivity ; Simulation ; Structure-Activity Relationship ; Sulfonamides ; Therapeutic applications ; Vibrio cholerae ; Vibrio cholerae - drug effects ; Vibrio cholerae - enzymology</subject><ispartof>International journal of molecular sciences, 2020-04, Vol.21 (9), p.3131</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443</citedby><cites>FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443</cites><orcidid>0000-0001-9928-4733 ; 0000-0003-3680-1945 ; 0000-0003-4262-0323 ; 0000-0002-1470-7192 ; 0000-0001-8416-0471</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2398062997/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2398062997?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,75096</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32365482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Demir-Yazıcı, Kübra</creatorcontrib><creatorcontrib>Güzel-Akdemir, Özlen</creatorcontrib><creatorcontrib>Angeli, Andrea</creatorcontrib><creatorcontrib>Supuran, Claudiu T</creatorcontrib><creatorcontrib>Akdemir, Atilla</creatorcontrib><title>Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium
(VcCA) presents an alternative therapeutic target. In this study, a series of hydrazone derivatives, carrying the 2-(hydrazinocarbonyl)-3-phenyl-1
-indole-5-sulfonamide scaffold, have been evaluated as inhibitors of the VcCA with molecular modeling studies. The results suggest that these compounds may bind to the active site of VcCA. To verify this, VcCA enzyme inhibition studies were performed and as predicted most of the tested compounds displayed potent inhibitory activities against VcCA with three compounds showing
values lower than 30 nM. In addition, all these compounds showed selectivity for VcCA and the off-targets hCA I and II.</description><subject>Amino Acid Sequence</subject><subject>Amino acids</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>Binding Sites</subject><subject>Carbonic anhydrase</subject><subject>Carbonic Anhydrase Inhibitors - chemistry</subject><subject>Carbonic Anhydrase Inhibitors - pharmacology</subject><subject>Cholera</subject><subject>Crystal structure</subject><subject>Drug development</subject><subject>Enzyme Activation</subject><subject>Enzymes</subject><subject>Epidemics</subject><subject>Gene expression</subject><subject>Hydrazones</subject><subject>Hydrazones - chemistry</subject><subject>Hydrogen bonds</subject><subject>Indoles</subject><subject>Indoles - chemistry</subject><subject>Inhibitors</subject><subject>Ligands</subject><subject>Molecular Conformation</subject><subject>Molecular Docking Simulation</subject><subject>Molecular Dynamics Simulation</subject><subject>Molecular modelling</subject><subject>Molecular Structure</subject><subject>Protein Binding</subject><subject>Selectivity</subject><subject>Simulation</subject><subject>Structure-Activity Relationship</subject><subject>Sulfonamides</subject><subject>Therapeutic applications</subject><subject>Vibrio cholerae</subject><subject>Vibrio cholerae - drug effects</subject><subject>Vibrio cholerae - enzymology</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkctu1TAURS1ERUthxhhZYtJBA34kTjxBaq9KW6mCDoCp5cdx46skLnZSqUz4Jn6Eb6ovfejC5PhIe3nbWxuhN5S851ySD2E9ZkaJ5JTTZ2iP1oxVhIj2-da-i17mvCaEcdbIF2iXMy6aumN76NfneAMDPp9cHKA61hkcPrt1Sf-ME2SsM76MM0xzIfpgwhxTxtHjuQf853dlB50zXulk4hQsPpr6zdUM2Kc44ks99_EKNsqxtjOksIz4ezApRGz78l7S8ArteD1keP1w7qNvn06-rs6qiy-n56uji8rWlM2V7ljrCWPeNrRlsnFONrqTDqiXvvWcA9GMCiI7YIQZQ5wR3nRGdrUUrq75Pvp473u9mBGcLZGSHtR1CqNOtyrqoP5VptCrq3ijWla3oiPF4ODBIMUfC-RZjSFbGAY9QVyyYlx2oi5TFPTdf-g6Lmkq8f5SRDAp20Id3lM2xZwT-KfPUKI2zartZgv-djvAE_xYJb8Dopmhjw</recordid><startdate>20200429</startdate><enddate>20200429</enddate><creator>Demir-Yazıcı, Kübra</creator><creator>Güzel-Akdemir, Özlen</creator><creator>Angeli, Andrea</creator><creator>Supuran, Claudiu T</creator><creator>Akdemir, Atilla</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9928-4733</orcidid><orcidid>https://orcid.org/0000-0003-3680-1945</orcidid><orcidid>https://orcid.org/0000-0003-4262-0323</orcidid><orcidid>https://orcid.org/0000-0002-1470-7192</orcidid><orcidid>https://orcid.org/0000-0001-8416-0471</orcidid></search><sort><creationdate>20200429</creationdate><title>Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae</title><author>Demir-Yazıcı, Kübra ; Güzel-Akdemir, Özlen ; Angeli, Andrea ; Supuran, Claudiu T ; Akdemir, Atilla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amino Acid Sequence</topic><topic>Amino acids</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>Binding Sites</topic><topic>Carbonic anhydrase</topic><topic>Carbonic Anhydrase Inhibitors - chemistry</topic><topic>Carbonic Anhydrase Inhibitors - pharmacology</topic><topic>Cholera</topic><topic>Crystal structure</topic><topic>Drug development</topic><topic>Enzyme Activation</topic><topic>Enzymes</topic><topic>Epidemics</topic><topic>Gene expression</topic><topic>Hydrazones</topic><topic>Hydrazones - chemistry</topic><topic>Hydrogen bonds</topic><topic>Indoles</topic><topic>Indoles - chemistry</topic><topic>Inhibitors</topic><topic>Ligands</topic><topic>Molecular Conformation</topic><topic>Molecular Docking Simulation</topic><topic>Molecular Dynamics Simulation</topic><topic>Molecular modelling</topic><topic>Molecular Structure</topic><topic>Protein Binding</topic><topic>Selectivity</topic><topic>Simulation</topic><topic>Structure-Activity Relationship</topic><topic>Sulfonamides</topic><topic>Therapeutic applications</topic><topic>Vibrio cholerae</topic><topic>Vibrio cholerae - drug effects</topic><topic>Vibrio cholerae - enzymology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Demir-Yazıcı, Kübra</creatorcontrib><creatorcontrib>Güzel-Akdemir, Özlen</creatorcontrib><creatorcontrib>Angeli, Andrea</creatorcontrib><creatorcontrib>Supuran, Claudiu T</creatorcontrib><creatorcontrib>Akdemir, Atilla</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Demir-Yazıcı, Kübra</au><au>Güzel-Akdemir, Özlen</au><au>Angeli, Andrea</au><au>Supuran, Claudiu T</au><au>Akdemir, Atilla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-04-29</date><risdate>2020</risdate><volume>21</volume><issue>9</issue><spage>3131</spage><pages>3131-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium
(VcCA) presents an alternative therapeutic target. In this study, a series of hydrazone derivatives, carrying the 2-(hydrazinocarbonyl)-3-phenyl-1
-indole-5-sulfonamide scaffold, have been evaluated as inhibitors of the VcCA with molecular modeling studies. The results suggest that these compounds may bind to the active site of VcCA. To verify this, VcCA enzyme inhibition studies were performed and as predicted most of the tested compounds displayed potent inhibitory activities against VcCA with three compounds showing
values lower than 30 nM. In addition, all these compounds showed selectivity for VcCA and the off-targets hCA I and II.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32365482</pmid><doi>10.3390/ijms21093131</doi><orcidid>https://orcid.org/0000-0001-9928-4733</orcidid><orcidid>https://orcid.org/0000-0003-3680-1945</orcidid><orcidid>https://orcid.org/0000-0003-4262-0323</orcidid><orcidid>https://orcid.org/0000-0002-1470-7192</orcidid><orcidid>https://orcid.org/0000-0001-8416-0471</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2020-04, Vol.21 (9), p.3131 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7247680 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central |
subjects | Amino Acid Sequence Amino acids Antibiotics Antimicrobial agents Bacteria Binding Sites Carbonic anhydrase Carbonic Anhydrase Inhibitors - chemistry Carbonic Anhydrase Inhibitors - pharmacology Cholera Crystal structure Drug development Enzyme Activation Enzymes Epidemics Gene expression Hydrazones Hydrazones - chemistry Hydrogen bonds Indoles Indoles - chemistry Inhibitors Ligands Molecular Conformation Molecular Docking Simulation Molecular Dynamics Simulation Molecular modelling Molecular Structure Protein Binding Selectivity Simulation Structure-Activity Relationship Sulfonamides Therapeutic applications Vibrio cholerae Vibrio cholerae - drug effects Vibrio cholerae - enzymology |
title | Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T13%3A22%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Indole-Based%20Hydrazones%20as%20Potent%20Inhibitors%20of%20the%20%CE%B1-class%20Carbonic%20Anhydrase%20from%20Pathogenic%20Bacterium%20Vibrio%20cholerae&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Demir-Yaz%C4%B1c%C4%B1,%20K%C3%BCbra&rft.date=2020-04-29&rft.volume=21&rft.issue=9&rft.spage=3131&rft.pages=3131-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21093131&rft_dat=%3Cproquest_pubme%3E2398642396%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2398062997&rft_id=info:pmid/32365482&rfr_iscdi=true |